DRUG:AU:AU-BetaShares Global Healthcare Currency Hedged (AUD)

ETF | Others |

Last Closing

USD 8.02

Change

+0.07 (+0.88)%

Market Cap

USD 0.17B

Volume

0.03M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-27 )

Largest Industry Peers for Others

ETFs Containing DRUG:AU

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.26% 24% F 56% F
Dividend Return 3.15% 46% F 38% F
Total Return 4.42% 21% F 56% F
Trailing 12 Months  
Capital Gain 1.26% 24% F 56% F
Dividend Return 3.15% 46% F 38% F
Total Return 4.42% 21% F 56% F
Trailing 5 Years  
Capital Gain 19.70% 63% D 70% C-
Dividend Return 10.89% 28% F 27% F
Total Return 30.59% 53% F 68% D+
Average Annual (5 Year Horizon)  
Capital Gain 7.02% 69% C- 55% F
Dividend Return 8.66% 68% D+ 54% F
Total Return 1.63% 57% F 37% F
Risk Return Profile  
Volatility (Standard Deviation) 8.43% 65% D 92% A
Risk Adjusted Return 102.66% 95% A 97% N/A
Market Capitalization 0.17B 34% F 65% D

Annual Financials (AUD)

Quarterly Financials (AUD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.